Production (Stage)
Creative Medical Technology Holdings, Inc.
CELZ
$2.11
-$0.0675-3.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.00K | 11.00K | 11.00K | 17.00K | 9.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.00K | 11.00K | 11.00K | 17.00K | 9.00K |
| Cost of Revenue | 5.60K | 4.40K | 4.40K | 6.80K | 3.60K |
| Gross Profit | 8.40K | 6.60K | 6.60K | 10.20K | 5.40K |
| SG&A Expenses | 3.46M | 3.24M | 3.24M | 3.28M | 3.46M |
| Depreciation & Amortization | 111.80K | 110.50K | 113.40K | 107.10K | 100.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.30M | 5.75M | 5.64M | 6.08M | 5.64M |
| Operating Income | -6.28M | -5.74M | -5.63M | -6.06M | -5.63M |
| Income Before Tax | -6.09M | -5.49M | -5.32M | -5.73M | -5.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.09 | -5.49 | -5.32 | -5.73 | -5.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.09M | -5.49M | -5.32M | -5.73M | -5.28M |
| EBIT | -6.28M | -5.74M | -5.63M | -6.06M | -5.63M |
| EBITDA | -6.17M | -5.63M | -5.52M | -5.96M | -5.53M |
| EPS Basic | -3.77 | -3.68 | -3.80 | -4.07 | -3.75 |
| Normalized Basic EPS | -2.36 | -2.30 | -2.38 | -2.55 | -2.34 |
| EPS Diluted | -3.77 | -3.68 | -3.80 | -4.07 | -3.75 |
| Normalized Diluted EPS | -2.36 | -2.30 | -2.38 | -2.55 | -2.34 |
| Average Basic Shares Outstanding | 6.48M | 5.92M | 5.60M | 5.64M | 5.64M |
| Average Diluted Shares Outstanding | 6.48M | 5.92M | 5.60M | 5.64M | 5.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |